Skip to main content
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site, you consent to the use of these cookies.

For US Healthcare Professionals Only

Assessing Blood Involvement in CTCL
(Cutaneous T-Cell Lymphoma)

Measuring the level of blood tumor involvement in CTCL patients is important for diagnosis, disease staging, prognosis and management.1

Photo Credit: Medical Images / Dorothea Zucker-Franklin

Flow cytometry is recommended in the NCCN Guidelines and European Organisation for Research and Treatment (EORTC) cutaneous lymphoma task force for objective assessment of malignant T-cell counts in CTCL subtypes Mycosis Fungoides and Sézary Syndrome.1,2 Despite the increased use of flow cytometry, there is a need for standardization of blood testing and comprehensive educational resources.3

Kyowa Kirin, Inc. has engaged several disease-state experts to provide information and resources about blood involvement in CTCL, why it matters, and how flow cytometry is used in testing for blood involvement.